← Leaderboards
Paul L Fidel
Louisiana State Univ Hsc New Orleans
$10,381,300
Attributed
$13,814,918
Total exposure
18
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,431,053 · 19
By mechanism
P20$14,205,337 · 6
R01$9,114,619 · 6
U19$499,462 · 1
R56$365,957 · 1
M01$208,178 · 2
R13$37,500 · 3
Top collaborators
- Ann L. Griffen5 shared
- Michael Edward Hagensee5 shared
- Eugene J Leys5 shared
- James E Cassat2 shared
- Brian M Peters2 shared
- Chad Steele1 shared
Most similar at Louisiana State Univ Hsc New Orleans
Same institution · by research overlap
- Michael Edward Hagensee$4,706,892
- Mary E Marquart$2,873,558
Others in their field
Top investigators on “Candida Albicans”
- Alexander D Johnson · University Of California San Francisco$23,545,370
- Aaron P Mitchell · La Biomed Res Inst/ Harbor Ucla Med Ctr$20,872,115
- Gavin J Sherlock · Stanford University$18,218,461
- Jay B Jackson · Johns Hopkins University$17,529,470
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$14,524,347
- Gerald R Fink · Whitehead Institute For Biomedical Res$14,278,186
Research focus
Candida AlbicansClinical ResearchCellular ImmunityCandidiasisMucosal ImmunityHelper T LymphocyteInfectionCytokineHuman SubjectOpportunistic InfectionsHiv InfectionsFemaleLeukocyte Activation /TransformationCandidaOralCytotoxic T LymphocyteOral PharyngealLaboratory MouseFunctional DisorderMicroorganism ImmunologyChemokineReportingMicrobialRisk Factors
Grant awards (48)
Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism$785,881
R01 · FY2025 · AI
21st Annual South Central Medical Mycology Meeting$6,500
R13 · FY2025 · AI · contact PI
Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism$822,646
R01 · FY2024 · AI
Candida mediated protection against polymicrobial sepsis$575,832
R01 · FY2023 · AI
South Central Medical Mycology Meeting 2017$6,000
R13 · FY2018 · AI · contact PI
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis$541,240
R01 · FY2017 · DE · contact PI
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis$597,308
R01 · FY2016 · DE · contact PI
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis$566,416
R01 · FY2015 · DE · contact PI
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis$554,339
R01 · FY2014 · DE · contact PI
The Oral Microbiome in HIV-associated Oral Warts and Candidiasis$505,165
R01 · FY2013 · DE · contact PI
CD8 Tcells and Tissue E-cadherin in Host Defense Against Oral Candidiasis in HIV$365,957
R56 · FY2012 · DE · contact PI
Mentoring Oral Health Research in Louisiana$200,000
P20 · FY2009 · RR · contact PI
Mentoring Oral Health Research in Louisiana$1,973,374
P20 · FY2008 · RR · contact PI
LSU DENTAL COBRE: ADMINISTRATIVE CORE$586,625
P20 · FY2008 · RR · contact PI
Mentoring Oral Health Research in Louisiana$1,966,390
P20 · FY2007 · RR · contact PI
LSU DENTAL COBRE: ADMINISTRATIVE CORE$467,707
P20 · FY2007 · RR · contact PI
Oral Immune Dysfunction and Candidiasis in HIV Infection$335,210
R01 · FY2007 · DE · contact PI
Mentoring Oral Health Research in Louisiana$2,017,435
P20 · FY2006 · RR · contact PI
LSU DENTAL COBRE: ADMINISTRATIVE CORE$452,612
P20 · FY2006 · RR · contact PI
Oral Immune Dysfunction and Candidiasis in HIV Infection$345,222
R01 · FY2006 · DE · contact PI
Oral Immune Dysfunction and Candidiasis in HIV Infection$248,500
R01 · FY2006 · DE · contact PI
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$213,000
R01 · FY2006 · AI · contact PI
ORAL IMMUNE DYSFUNCTION AND ORAL INFECTIOUS DISEASE IN HIV INFECTION$148,290
M01 · FY2006 · RR · contact PI
8th ASM Conference on Candida and Candidiasis$25,000
R13 · FY2006 · DE · contact PI
Mentoring Oral Health Research in Louisiana$2,024,832
P20 · FY2005 · RR
LSU DENTAL COBRE: ADMINISTRATIVE CORE$913,888
P20 · FY2005 · RR
Oral Immune Dysfunction and Candidiasis in HIV Infection$353,530
R01 · FY2005 · DE
ORAL IMMUNE DYSFUNCTION AND ORAL INFECTIOUS DISEASE IN HIV INFECTION$59,888
M01 · FY2005 · RR
Mentoring Oral Health Research in Louisiana$2,434,104
P20 · FY2004 · RR
LSU DENTAL COBRE: ADMINISTRATIVE CORE$1,168,370
P20 · FY2004 · RR
Oral Immune Dysfunction and Candidiasis in HIV Infection$353,530
R01 · FY2004 · DE
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$214,500
R01 · FY2004 · AI
Oral Immune Dysfunction and Candidiasis in HIV Infection$347,230
R01 · FY2003 · DE
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$214,500
R01 · FY2003 · AI
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$203,775
R01 · FY2002 · AI
CONTRIBUTION OF REPRODUCTIVE HORMONES TO VAGINAL IMMUNOLOGY$180,480
U19 · FY2002 · AI
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$229,152
R01 · FY2001 · DE
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$214,500
R01 · FY2001 · AI
CONTRIBUTION OF REPRODUCTIVE HORMONES TO VAGINAL IMMUNOLOGY$180,480
U19 · FY2001 · AI
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$108,940
R01 · FY2001 · DE
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$26,240
R01 · FY2001 · DE
CONTRIBUTION OF REPRODUCTIVE HORMONES TO VAGINAL IMMUNOLOGY$0
U19 · FY2001 · AI
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$222,477
R01 · FY2000 · DE
MUCOSAL CELL MEDIATED IMMUNITY IN VAGINAL CANDIDIASIS$203,750
R01 · FY2000 · AI
HORMONAL REGULATION OF VIGINAL IMMUNITY TO C ALBICANS$200,347
R01 · FY2000 · AI
CONTRIBUTION OF REPRODUCTIVE HORMONES TO VAGINAL IMMUNOLOGY$138,502
U19 · FY2000 · AI
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$105,767
R01 · FY2000 · DE
ORAL IMMUNE DYSFUNCTION AND CANDIDIASIS IN HIV INFECTION$25,622
R01 · FY2000 · DE